The Scientist

» vaccine and immunology

Most Recent

image: Looking for Latent HIV

Looking for Latent HIV

By Jenny Rood | May 1, 2015

Sequencing HIV integration sites suggests that clonally expanded T-cell populations may not be the main source of latent virus.


image: Soluble Signal

Soluble Signal

By Jenny Rood | May 1, 2015

An immune protein previously thought to mark inactive T cells has a free-floating form that correlates with HIV disease progression.


image: Defeating the Virus

Defeating the Virus

By Wayne C. Koff | May 1, 2015

Recent discoveries are spurring a renaissance in HIV vaccine research and development.


image: Protein Spurs T-Cell Proliferation

Protein Spurs T-Cell Proliferation

By Jef Akst | April 17, 2015

A newly discovered protein promotes immunity to viruses and cancer by triggering the production of cytotoxic T cells.

1 Comment

image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By Jef Akst | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.


image: Studying Ebola Survivors

Studying Ebola Survivors

By Amanda B. Keener | April 6, 2015

A scientist jumps at the chance to study the blood of four Ebola survivors to better understand how the immune system responds to the deadly virus. 

1 Comment

image: Cancer Immunotherapist

Cancer Immunotherapist

By Jef Akst | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

1 Comment

image: Manipulative Microbiomes

Manipulative Microbiomes

By Jenny Rood | April 1, 2015

Gut bacteria control tumor growth via the mammalian immune system.


image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By Jef Akst | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41


image: Ebola Vax Trial Update

Ebola Vax Trial Update

By Jef Akst | March 26, 2015

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.


Popular Now

  1. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  2. University of Oregon Erecting a $1-Billion Science Center
  3. Could Rapamycin Help Humans Live Longer?
  4. Investigation Finds Signs of Misconduct in Swedish Researcher’s Papers